ClinicalTrials.Veeva

Menu

NSAIDs in Coronary Artery Disease Patients

H

Heinrich-Heine University, Duesseldorf

Status

Completed

Conditions

CAD

Study type

Observational

Funder types

Other

Identifiers

NCT01402804
AGP-0001

Details and patient eligibility

About

Introduction:

Different groups already showed in retrospective subgroup analyses, that there is an increased risk for cardiovascular events in patients on a simultaneous ASA/NSAID treatment.

Methods:

Light-Transmission aggregometry

Hypothesis:

Simultaneous administration of different NSAIDs and ASA impair the platelet inhibiting effect of ASA.

Enrollment

85 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients on a simultaneous ASA, NSAID treatment
  • > 18 years

Exclusion criteria

  • unconsciousness, not able to consent
  • reanimation, cardiac shock

Trial design

85 participants in 2 patient groups

Stable CAD, ASA, NSAID
Stable CAD, ASA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems